OIG March 2018 Report: “Drug Supply Chain Security: Dispensers Received Most Tracing Information”

image02

In March 2018, The Office of Inspector General (OIG) issued its second in a series of three anticipated examinations of drug supply chain security focusing on the implementation the Drug Supply Chain Security Act (DSCSA). The report focuses on the survey results of 40 healthcare/retail pharmacy organizations:

  • 20 independent/chain retail pharmacies, and
  • 20 small/large hospitals/health systems

Read the Report

The FDA has also issued two (2) recent guidance documents regarding: